Stockscreener 앱 받기
1.64
6.29%
-0.11
시간 외 거래:
1.64
전일 마감가:
$1.75
열려 있는:
$1.72
하루 거래량:
304.83K
Relative Volume:
0.40
시가총액:
$103.47M
수익:
$139.77M
순이익/손실:
$-97.62M
주가수익비율:
-1.038
EPS:
-1.58
순현금흐름:
$-61.71M
1주 성능:
+0.00%
1개월 성능:
+54.72%
6개월 성능:
-56.50%
1년 성능:
-89.53%
1일 변동 폭
$1.63
$1.74
1주일 범위
$1.535
$1.815
52주 변동 폭
$0.9897
$16.44
Macrogenics Inc Stock (MGNX) Company Profile
명칭
Macrogenics Inc
전화
301-251-5172
주소
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.64 | 103.47M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-05-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-04-26 | 개시 | B. Riley Securities | Buy |
| 2024-04-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-03-04 | 재확인 | BTIG Research | Buy |
| 2024-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-11-22 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-14 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | 다운그레이드 | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-02-28 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-02-04 | 개시 | SMBC Nikko | Outperform |
| 2021-11-17 | 재개 | Guggenheim | Buy |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 업그레이드 | Barclays | Underweight → Overweight |
| 2020-12-22 | 재개 | H.C. Wainwright | Buy |
| 2020-08-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-06-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-05-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2019-12-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-11-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-05-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2019-04-12 | 개시 | Guggenheim | Neutral |
| 2019-02-07 | 업그레이드 | Citigroup | Sell → Buy |
| 2019-02-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-02-06 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-12-10 | 다운그레이드 | Raymond James | Outperform → Underperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-03-05 | 개시 | H.C. Wainwright | Buy |
| 2017-03-31 | 개시 | Raymond James | Outperform |
모두보기
Macrogenics Inc 주식(MGNX)의 최신 뉴스
Macrogenics Inc: Is MGNX Stock Worth Buying? - Stocksregister
Press Release Distribution & PR Platform - ACCESS Newswire
LPL Financial LLC Sells 8,500 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
MacroGenics to Participate in Upcoming Investor Conference | MGN - GuruFocus
MacroGenics to Participate in Upcoming Investor Conference - The Manila Times
MacroGenics Announces Exclusive Fireside Chat at Major Life Sciences ConferenceKey Details Inside - Stock Titan
A year in review: Macrogenics Inc (MGNX)’s performance in the last year - uspostnews.com
Quarterly Snapshot: Quick and Current Ratios for Macrogenics Inc (MGNX) - DWinneX
MacroGenics (MGNX) to Release Earnings on Thursday - Defense World
MacroGenics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - ACCESS Newswire
MacroGenics, Inc. (NASDAQ:MGNX) Holdings Increased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Acquires 221,905 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MGNXMacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN
The MGNX Stock Puzzle: Unraveling Macrogenics Inc’s Fluctuating Performance - investchronicle.com
MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
MacroGenics Provides Update on Corporate Progress and First Quarter 2019 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and Third Quarter 2015 Financial Results - ADVFN
Investor Expectations to Drive Momentum within LPL Financial, Comcast, MacroGenics, Wayfair, Masimo, and Big Lots — Discove... - ADVFN
MacroGenics Provides Update on Corporate Progress and Second Quarter 2019 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results - ADVFN
MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results - ADVFN
Comparing Ensysce Biosciences (NASDAQ:ENSC) & MacroGenics (NASDAQ:MGNX) - Defense World
MacroGenics, Inc. (NASDAQ:MGNX) Receives $7.38 Average Price Target from Analysts - Defense World
MacroGenics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMGNX - marketscreener.com
American Century Companies Inc. Buys Shares of 11,743 MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MacroGenics, Inc. (NASDAQ:MGNX) Looks Inexpensive After Falling 42% But Perhaps Not Attractive Enough - simplywall.st
Wellington Management Group LLP Acquires 16,717 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Macrogenics Inc (MGNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):